Volume 35, Issue 3 | Cardiovascular Drugs and Therapy

Search all Cardiovascular Drugs and Therapy articles

Volume 35, Issue 3

June 2021

Supplement: Translating Genomic Medicine to Treatments (pages 613-690)

Issue Editor:

Eugene Chen

23 articles in this issue

Impact of COVID-19 on the Cardiovascular System: A Review of Available Reports
R. S. Soumya
T. Govindan Unni
K. G. Raghu
Review Article 14 September 2020 Pages: 411 - 425
Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications
Shubham Agarwal
Sanjeev Kumar Agarwal
Review Article 12 September 2020 Pages: 427 - 440
Major Cardiac–Psychiatric Drug–Drug Interactions: a Systematic Review of the Consistency of Drug Databases
João Mauricio Castaldelli-Maia
Caio Hofmann
Andreas Wielgosz
Review Article 19 May 2020 Pages: 441 - 454
The Potential of Albuminuria as a Biomarker of Diabetic Complications
Pappitha Raja
Alexander P. Maxwell
Derek P. Brazil
Review Article Open access 17 July 2020 Pages: 455 - 466
Research Progress on the Involvement of ANGPTL4 and Loss-of-Function Variants in Lipid Metabolism and Coronary Heart Disease: Is the “Prime Time” of ANGPTL4-Targeted Therapy for Coronary Heart Disease Approaching?
Jingmin Yang
Xiao Li
Danyan Xu
Review Article 04 June 2020 Pages: 467 - 477
Concepts and Controversies: Lipid Management in Patients with Chronic Kidney Disease
Roy O. Mathew
Robert S. Rosenson
Mandeep S. Sidhu
Review Article 18 June 2020 Pages: 479 - 489
Metformin Lowers Body Weight But Fails to Increase Insulin Sensitivity in Chronic Heart Failure Patients without Diabetes: a Randomized, Double-Blind, Placebo-Controlled Study
Anders Hostrup Larsen
Henrik Wiggers
Niels Jessen
Original Article 08 August 2020 Pages: 491 - 503
The Impairment in Kidney Function in the Oral Anticoagulation Era. A Pathophysiological Insight
Pietro Scicchitano
Marco Tucci
Marco Matteo Ciccone
Review Article 13 June 2020 Pages: 505 - 519
Apixaban Downregulates Endothelial Inflammatory and Prothrombotic Phenotype in an In Vitro Model of Endothelial Dysfunction in Uremia
Sergi Torramade-Moix
Marta Palomo
Maribel Diaz-Ricart
Original Article 10 July 2020 Pages: 521 - 532
Eligibility for Low-Dose Rivaroxaban Based on the COMPASS Trial: Insights from the Veterans Affairs Healthcare System
Akash Kataruka
Dhruv Mahtta
Salim S. Virani
Short Communication 03 September 2020 Pages: 533 - 538
Cost-effectiveness analysis of rivaroxaban plus aspirin versus aspirin alone in secondary prevention among patients with chronic cardiovascular diseases
Mei-Chuan Lee
Chia-Te Liao
Carol Strong
Original Article 10 September 2020 Pages: 539 - 547
Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel Pharmacogenomics
Joel A. Morales-Rosado
Kashish Goel
Naveen L. Pereira
Original Article 04 July 2020 Pages: 549 - 559
Prasugrel Versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a Systematic Review and Meta-analysis of Randomized Trials
Avik Ray
Ahmad Najmi
Balakrishnan Sadasivam
Original Article 20 August 2020 Pages: 561 - 574
Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Patients with Left Ventricular Systolic Dysfunction
Mahin R. Khan
Waleed T. Kayani
Hani Jneid
Review Article 09 September 2020 Pages: 575 - 585
Attenuation of atrial remodeling by aliskiren via affecting oxidative stress, inflammation and PI3K/Akt signaling pathway
Zhiqiang Zhao
Ruiling Li
Guangping Li
Original Article 27 May 2020 Pages: 587 - 598
TAK1-AMPK Pathway in Macrophages Regulates Hypothyroid Atherosclerosis
Yunxiao Yang
Yifan Jia
Ming Zhang
Original Article 03 June 2020 Pages: 599 - 612
Translating Cardiovascular Genomics to Clinical Practice
Y. Eugene Chen
Editorial 14 April 2021 Pages: 613 - 615
Part of 1 collection:

Translating genome medicine to treatments
Translating genetic association of lipid levels for biological and clinical application
Bradley Crone
Amelia M. Krause
Ida Surakka
Invited Review Article 19 February 2021 Pages: 617 - 626
Part of 1 collection:

Translating genome medicine to treatments
Polygenic Risk Score: Clinically Useful Tool for Prediction of Cardiovascular Disease and Benefit from Lipid-Lowering Therapy?
Natalie Arnold
Wolfgang Koenig
Invited Review Article Open access 06 November 2020 Pages: 627 - 635
Part of 1 collection:

Translating genome medicine to treatments
Integration of Transformative Platforms for the Discovery of Causative Genes in Cardiovascular Diseases
Haocheng Lu
Jifeng Zhang
Minerva T. Garcia-Barrio
Invited Review Article 15 April 2021 Pages: 637 - 654
Part of 1 collection:

Translating genome medicine to treatments
Targeting Human lncRNAs for Treating Cardiometabolic Diseases
Xiangbo Ruan
Invited Review Article 20 February 2021 Pages: 655 - 662
Part of 1 collection:

Translating genome medicine to treatments
The Interface of Therapeutics and Genomics in Cardiovascular Medicine
E. F. Magavern
J. C. Kaski
M. Pirmohamed
Invited Review Article 02 February 2021 Pages: 663 - 676
Part of 1 collection:

Translating genome medicine to treatments
Genetics of Triglyceride-Rich Lipoproteins Guide Identification of Pharmacotherapy for Cardiovascular Risk Reduction
Aleesha Shaik
Robert S. Rosenson
Invited Review Article 12 March 2021 Pages: 677 - 690
Part of 1 collection:

Translating genome medicine to treatments